Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

88.76 -1.27 (-1.41%)

Streaming Delayed Price Updated: 12:38 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

"Animal Spirits" Return: Morgan Stanley Signals M&A Renaissance as Healthcare and Industrials Lead Shifting Landscape

January 15, 2026

As 2026 begins, the global mergers and acquisitions (M&A) market is witnessing a profound "renaissance," driven by a confluence of stabilizing interest rates, record levels of corporate cash, and a...

Via MarketMinute

Exploring the top movers within the S&P500 index during today's session. ↗

January 15, 2026

Via Chartmill

Why Boston Scientific (BSX) Stock Is Down Today

January 15, 2026

Shares of medical device company Boston Scientific (NYSE:BSX) fell 4.6% in the afternoon session after the company agreed to acquire Penumbra in a transaction valued at approximately $14.5 billion,...

Via StockStory

Penumbra Shares Soar Pre-Market — What Is The Boston Scientific Agreement? ↗

January 15, 2026

Via Stocktwits

What's going on in today's session: S&P500 movers ↗

January 15, 2026

Via Chartmill

The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition

January 15, 2026

MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

January 15, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Thursday's session: gap up and gap down stock in the S&P500 index ↗

January 15, 2026

Via Chartmill

1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

January 12, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Medtronic (MDT) Deep-Dive: Can the MedTech Giant Outpace the Market in 2026?

January 09, 2026

Date: January 9, 2026 Introduction As the global healthcare landscape undergoes a seismic shift toward personalized medicine and AI-integrated care, Medtronic plc (NYSE: MDT) stands at a critical...

Via PredictStreet

Topics Artificial Intelligence Economy Product Recall

2 Growth Stocks to Add to Your Roster and 1 We Find Risky

January 08, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...

Via StockStory

The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026

January 06, 2026

As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence...

Via MarketMinute

Topics Artificial Intelligence Economy Government

The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature

January 01, 2026

As of today, January 1, 2026, Abbott Laboratories (NYSE: ABT) stands as one of the most resilient and strategically diversified giants in the global healthcare landscape. While the broader market has...

Via PredictStreet

Topics Economy Lawsuit World Trade

Earnings Renaissance: Why 2026 Profit Projections are Propping Up Record Valuations

December 24, 2025

As 2025 draws to a close, the financial markets are entering the new year with a sense of cautious exuberance. Despite a year of navigating fluctuating interest rates and geopolitical tensions, the...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗

December 24, 2025

This basket of 64 medical device stocks could raise its dividend for decades.

Via The Motley Fool

Topics ETFs Government Supply Chain

1 Safe-and-Steady Stock with Promising Prospects and 2 We Ignore

December 21, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

2 Profitable Stocks to Consider Right Now and 1 We Turn Down

December 18, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Topics Supply Chain

Explore the top gainers and losers within the S&P500 index in today's session. ↗

December 08, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

December 08, 2025

Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & Supplies - Diversified Segment

November 24, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best...

Via StockStory

UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers

November 20, 2025

New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's...

Via MarketMinute

Topics Artificial Intelligence Economy

$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today ↗

November 18, 2025

Via Benzinga

2 Reasons to Watch BSX and 1 to Stay Cautious

November 16, 2025

Boston Scientific has been treading water for the past six months, recording a small loss of 3.5% while holding steady at $102.88. The stock also fell short of the S&P 500’s 13% gain during that...

Via StockStory

Topics Stocks

3 Market-Beating Stocks with Solid Fundamentals

November 13, 2025

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...

Via StockStory

1 High-Flying Stock with Promising Prospects and 2 That Underwhelm

November 11, 2025

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

Via StockStory

1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Ignore

November 10, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Topics Electric Vehicles

A Look Into Boston Scientific Inc's Price Over Earnings ↗

November 07, 2025

Via Benzinga

Boston Scientific Corp (NYSE:BSX) Shows Strong Growth and Bullish Technical Setup ↗

November 07, 2025

Discover Boston Scientific (BSX), a top growth stock with strong earnings, revenue acceleration, and a bullish technical setup signaling a potential price surge.

Via Chartmill

1 Safe-and-Steady Stock to Keep an Eye On and 2 We Question

November 02, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

2 Large-Cap Stocks Worth Investigating and 1 That Underwhelm

October 31, 2025

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.